Sahil Khanna Selected Research

Colorectal Neoplasms (Colorectal Cancer)

7/2013

Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sahil Khanna Research Topics

Disease

50	Clostridium Infections 01/2024 - 07/2012
21	Infections 11/2023 - 01/2012
15	Diarrhea 11/2023 - 08/2015
11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 07/2013
6	Dysbiosis 01/2022 - 01/2016
5	Microscopic Colitis 11/2023 - 02/2013
5	Neoplasms (Cancer) 10/2021 - 07/2013
5	COVID-19 01/2021 - 01/2020
4	Obesity 10/2021 - 01/2014
4	Colitis 10/2021 - 07/2015
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2024 - 01/2017
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2023 - 02/2020
3	Reinfection 01/2022 - 07/2012
3	Melanoma (Melanoma, Malignant) 10/2021 - 07/2015
3	Ulcerative Colitis 01/2018 - 01/2016
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2014
3	Crohn Disease (Crohn's Disease) 01/2018 - 02/2013
2	Hypertension (High Blood Pressure) 08/2023 - 01/2020
2	Urinary Tract Infections (Urinary Tract Infection) 08/2023 - 10/2017
2	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 01/2019 - 01/2017
1	Liver Diseases (Liver Disease) 11/2023
1	Hyperglycemia 08/2023
1	Metabolic Bone Diseases (Osteopenia) 08/2023
1	Glaucoma 08/2023
1	Cataract (Cataracts) 08/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Overweight 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Polyps 01/2018
1	Diabetes Mellitus 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Surgical Wound Infection 01/2017
1	Pouchitis 01/2017
1	Anastomotic Leak 01/2017
1	Fistula 01/2017
1	Hemorrhage 01/2017
1	Coinfection 11/2016
1	Body Weight (Weight, Body) 08/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2013
1	Sclerosing Cholangitis 07/2013

Drug/Important Bio-Agent (IBA)

28	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2012
6	Vancomycin FDA LinkGeneric 11/2023 - 06/2014
5	FidaxomicinIBA 11/2023 - 11/2012
5	Monoclonal AntibodiesIBA 01/2022 - 11/2012
4	Budesonide (Pulmicort)FDA LinkGeneric 08/2023 - 02/2013
4	Proton Pump InhibitorsIBA 01/2021 - 07/2012
3	IpilimumabIBA 10/2021 - 07/2015
3	VaccinesIBA 01/2021 - 08/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 02/2013
2	Bile Acids and Salts (Bile Acids)IBA 11/2023 - 01/2021
2	Metronidazole (Metric)FDA LinkGeneric 01/2021 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2018
2	Immunologic Factors (Immunomodulators)IBA 01/2019 - 01/2018
2	TetracyclinesIBA 01/2018 - 01/2018
2	SteroidsIBA 01/2017 - 08/2015
2	Prednisone (Sone)FDA LinkGeneric 08/2015 - 02/2013
1	phosphatidylethanolIBA 11/2023
1	EnzymesIBA 01/2023
1	Apolipoproteins B (ApoB)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	HDL CholesterolIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	LipidsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	remdesivirIBA 01/2021
1	bezlotoxumabIBA 01/2021
1	actoxumabIBA 01/2021
1	IgYIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Anti-Infective Agents (Microbicides)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Amino Acids FDA Link 10/2018
1	Proline (L-Proline)FDA Link 10/2018
1	Shiga Toxin (Shigella Toxin)IBA 01/2018
1	Histamine H2 AntagonistsIBA 01/2017
1	Infliximab (Remicade)FDA Link 08/2015
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 07/2013

Therapy/Procedure

30	Fecal Microbiota Transplantation 01/2024 - 11/2012
27	Therapeutics 05/2024 - 11/2012
3	Colectomy 01/2021 - 11/2016
2	Transplantation 01/2022 - 07/2015
1	Aftercare (After-Treatment) 03/2022
1	Retreatment 03/2022
1	Personal Protective Equipment 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Donor Selection 01/2021
1	Organ Transplantation 01/2019
1	Length of Stay 01/2018
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Drug Therapy (Chemotherapy) 11/2017
1	Ileostomy 01/2017
1	Restorative Proctocolectomy 01/2017
1	Appendectomy 04/2013